MaenAHusseinMD

Oncology • Lady Lake, FL

Physician

Join to view full profile

Dr. Hussein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hussein's full profile

Already have an account?

Office
Florida Cancer Specialists (VCC)
1400 N US Hwy 441, Suite 540
Lady Lake, FL 32159
Phone+1 352-753-9777

Fax+1 866-446-1888
Is this information wrong?

Education & Training

St Louis University School of MedicineFellowship, Hematology and Medical Oncology, 2002 - 2005
Brown UniversityResidency, Internal Medicine, 1999 - 2002
University of Jordan Faculty of MedicineClass of 1996

Certifications & Licensure

FL State Medical License 2006 - 2025
RI State Medical License 2005 - 2006
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014

Clinical Trials

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts Start of enrollment: 2010 Nov 01
Completed
Phase 3
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
Completed
A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants Start of enrollment: 2013 Aug 01
Completed
Phase 2
A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Start of enrollment: 2014 Apr 09
Completed
Phase 3
A Study of LY3023414 and Necitumumab in Squamous Lung Cancer Start of enrollment: 2015 Jul 01
Terminated
Phase 2
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) Start of enrollment: 2015 Jun 26
Completed
Phase 1, Phase 2
Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy Start of enrollment: 2015 Oct 05
Terminated
Phase 1, Phase 2
A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer Start of enrollment: 2016 May 11
Completed
Phase 2
A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer Start of enrollment: 2019 Apr 01
Active, not recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by...
Edward B Garon, Byoung Chul Cho, Alexander Luft, Jorge Alatorre-Alexander, Sarayut Lucien Geater, Dmytro Trukhin, Sang-We Kim, Grygorii Ursol, Maen Hussein, Farah Loui...> ;Clinical Lung Cancer. 2024 Mar 15
Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations.
David S Hong, Federico Cappuzzo, Byoung Chul Cho, Afshin Dowlati, Maen Hussein, Dong-Wan Kim, Ivor Percent, James G Christensen, Josée Morin, Diane Potvin, Demiana Fal...> ;Lung Cancer. 2024 Apr 1
A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.
Riely, G., Smit, E., Ahn, M., Felip, E., Ramalingam, S., Tsao, A., Johnson, M., Gelsomino, F., Esper, R., Nadal, E., Offin, M., Provencio, M., Clarke, J., Hussein, M.,...> ;Future Oncology. 2024 Feb 15
Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON).
Edward B Garon, Byoung Chul Cho, Alexander Luft, Jorge Alatorre-Alexander, Sarayut Lucien Geater, Sang-We Kim, Grygorii Ursol, Maen Hussein, Farah Louise Lim, Cheng-Ta...> ;Lung Cancer. 2023 Dec 1
6 citations
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial.
Tina Cascone, Gozde Kar, Jonathan D Spicer, Rosario García-Campelo, Walter Weder, Davey B Daniel, David R Spigel, Maen Hussein, Julien Mazieres, Julio Oliveira, Edwin ...> ;Cancer Discovery. 2023 Nov 1
1 citations
Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION Study.
Myung-Ju Ahn, Igor Bondarenko, Ewa Kalinka, Byoung Chul Cho, Shunichi Sugawara, Gabriella Gálffy, Byoung Yong Shim, Nikolay Kislov, Rajnish Nagarkar, Ingel Demedts, St...> ;Journal of Thoracic Oncology. 2023 Nov 1
5 citations
Monoclonal gammopathy of thrombotic/thrombocytopenic significance.
Adam J Kanack, Jordan K Schaefer, Meera Sridharan, Noah P Splinter, Mindy C Kohlhagen, Bandana Singh, Silvana B De Lorenzo, Emily E Mauch, Maen A Hussein, Marwan Shaik...> ;Blood. 2023 Apr 6
84 citations
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study.
Melissa L Johnson, Byoung Chul Cho, Alexander Luft, Jorge Alatorre-Alexander, Sarayut Lucien Geater, Konstantin Laktionov, Sang-We Kim, Grygorii Ursol, Maen Hussein, F...> ;Journal of Clinical Oncology. 2023 Feb 20
112 citations
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-...
Byoung Chul Cho, Delvys Rodriguez Abreu, Maen Hussein, Manuel Cobo, Anjan J Patel, Nevena Secen, Ki Hyeong Lee, Bartomeu Massuti, Sandrine Hiret, James Chih Hsin Yang,...> ;The Lancet. Oncology. 2022 Jun 1
10 citations
Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three...
Maen A. Hussein, Marina Maglakelidze, Donald A. Richards, Marielle Sabatini, Todd A Gersten, Keith Lerro, Ivan Sinielnikov, Alexander I. Spira, Yili Pritchett, Joyce M...> ;Cancer Management and Research. 2021 Aug 9
65 citations
Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study
Lowell L. Hart, Renata Ferrarotto, Z. Andric, J. Thaddeus Beck, Janakiraman Subramanian, Davorin Radosavljevic, Bojan Zaric, Wahid Hanna, Raid Aljumaily, Taofeek K. Ow...> ;Advances in Therapy. 2021 Jan 1
91 citations
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153.
David M. Waterhouse, Edward B. Garon, Jason C. Chandler, Michael McCleod, Maen A. Hussein, Robert M. Jotte, Leora Horn, Davey B. Daniel, George P. Keogh, Ben C. Creela...> ;Journal of Clinical Oncology. 2020 Sep 10
284 citations
Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial
Robert M. Jotte, Federico Cappuzzo, Ihor Vynnychenko, Daniil Stroyakovskiy, Delvys Rodriguez-Abreu, Maen A. Hussein, Ross A. Soo, Henry J. Conter, Toshiyuki Kozuki, Ku...> ;Journal of Thoracic Oncology. 2020 Aug 1
16 citations
The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC).
Johanna C Bendell, Tamara Sauri, Antonio Cubillo Gracián, Rafael Alvarez, Carlos López-López, Pilar García-Alfonso, Maen Hussein, Maria-Luisa Limon Miron, Andrés Cerva...> ;The Oncologist. 2020 Mar 1
123 citations
Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer, Including...
David R. Spigel, Michael McCleod, Robert M. Jotte, Lawrence H. Einhorn, Leora Horn, David M. Waterhouse, Ben C. Creelan, Sunil Babu, Natasha B. Leighl, Jason C. Chandl...> ;Journal of Thoracic Oncology. 2019 Sep 1
908 citations
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-...
Howard Jack West, Michael McCleod, Maen A. Hussein, Alessandro Morabito, Achim Rittmeyer, Henry Jacob Conter, Hans-Georg Kopp, Davey B. Daniel, Steven L. McCune, Tarek...> ;The Lancet. Oncology. 2019 Jul 1
90 citations
PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer
Hui Yu, Cory Batenchuk, Andrzej Badzio, Theresa A. Boyle, Piotr Czapiewski, Daniel C. Chan, Xian Lu, Dexiang Gao, Kim Ellison, Ashley Kowalewski, Christopher J. Rivard...> ;Journal of Thoracic Oncology. 2017 Jan 1
Join now to see all

Press Mentions

Oncologists Face Nightmares Every Day with Prior AuthorizationAugust 5th, 2021
In Florida, Serving the Senior Population in Oncology Means Working TogetherApril 11th, 2020
Dr Maen Hussein on How Changes in Medicare Hospice Coverage Impact Community Oncology PracticesMarch 21st, 2020
Join now to see all